Trial Profile

Dose-Ranging Study to Evaluate the Safety, Tolerability and Immunogenicity of INO-4500 in Combination With Electroporation in Healthy Volunteers in Ghana

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 22 Nov 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs INO 4500 (Primary)
Indications Lassa fever
Focus Adverse reactions; Pharmacodynamics
Acronyms LSV002
Sponsors Inovio Pharmaceuticals

Most Recent Events

30 Sep 2022 Status changed from active, no longer recruiting to completed.
26 Oct 2021 According to an Inovio Pharmaceuticals media release, the company has completed the enrollment of patients in this study.
26 Oct 2021 Status changed from recruiting to active, no longer recruiting, according to an Inovio Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com